Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 1 h ago
Peer-reviewedCC BYMedical Mycology Case Reports

Laryngeal cryptococcosis with clinical failure to fluconazole in a patient with common variable immunodeficiency: A treatment dilemma

  1. 1Henry Ford Hospital, Division of Infectious Diseases, 2799 W Grand Blv, Detroit, MI, 48322, USA
  2. 2Henry Ford Hospital, Department of Otolaryngology, 2799 W Grand Blv, Detroit, MI, 48322, USA
  3. 3Henry Ford Hospital, Division of Infectious Diseases, 2799 W Grand Blv, Detroit, MI, 48322, USA; Corresponding author. 2799 W Grand Blvd, CFP-322, Detroit, MI, 48202, USA.

Abstract

We describe the case of a 57-year-old female with chronic hoarseness and cough whose laryngeal exam revealed chronic laryngitis with exudates. She failed multiple courses of fluconazole for presumed laryngeal candidiasis. Pathology demonstrated laryngeal cryptococcosis, and sputum cultures grew Cryptococcus neoformans with an elevated fluconazole MIC. Immunological evaluation led to the diagnosis of common variable immunodeficiency. After complications with alternative antifungals, the patient responded favorably to isavuconazole and intravenous immunoglobulin replacement.

Related

  1. Doravirine/islatravir (DOR-ISL) as a new once-daily oral single-tablet regimen for human immunodeficiency virus (HIV) treatment: unmet need or paradox of choice?
    Amit C Achhra, Onyema E Ogbuagu
    Annals of Translational MedicinePeer-reviewedCC BY-NC-ND 4.0Full textInfectious diseasePMC
  2. Clinical correlates for fluconazole resistance in Candida bloodstream infections.
    Zihuan Li, Tian Wang, Mengdie Zhang +5
    Frontiers in public healthPeer-reviewedCC BYFull textInfectious diseaseEurope PMCCrossref
  3. Botox Injection Combined With Partial Arytenoidectomy: A Novel Approach for Treatment of Episodic Laryngeal Breathing Disorders
    Zhou Zhou, Jia-Hui Wu, Pei-Kai Yan +3
    World journal of otorhinolaryngology - head and neck surgeryPeer-reviewedCC BYFull textGeneral medicineEurope PMCEurope PMCPMC
  4. Variant Classification of a Non-Protein Coding Gene: ACMG/AMP Specifications for RMRP from the Clinical Genome Resource Severe Combined Immunodeficiency Disease Variant Curation Expert Panel
    V. C. Jacovas, Y. Demirkol, A. Nieto-Patlan +21
    medRxivPreprintAll rights reservedFull textHuman geneticsmedRxiv
  5. The clinical spectrum of hepatic cystic echinococcosis in a population with high human immunodeficiency virus prevalence: a retrospective cohort study in South Africa
    Kate Couzens-Bohlin, Urda Kotze, Jeandre Malherbe +7
    IJID regionsPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMCPMCEurope PMC
BibTeX
@article{alvi2026laryngeal,
  title = {{Laryngeal cryptococcosis with clinical failure to fluconazole in a patient with common variable immunodeficiency: A treatment dilemma}},
  author = {Rija Binte Rehan Alvi and Ross M. Mayerhoff and Eloy E. Ordaya},
  journal = {Medical Mycology Case Reports},
  year = {2026},
  month = oct,
  doi = {10.1016/j.mmcr.2026.100831},
  url = {https://doi.org/10.1016/j.mmcr.2026.100831},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Laryngeal cryptococcosis with clinical failure to fluconazole in a patient with common variable immunodeficiency: A treatment dilemma
AU  - Rija Binte Rehan Alvi
AU  - Ross M. Mayerhoff
AU  - Eloy E. Ordaya
PY  - 2026
DA  - 2026/10/31
JO  - Medical Mycology Case Reports
DO  - 10.1016/j.mmcr.2026.100831
UR  - https://doi.org/10.1016/j.mmcr.2026.100831
AB  - We describe the case of a 57-year-old female with chronic hoarseness and cough whose laryngeal exam revealed chronic laryngitis with exudates. She failed multiple courses of fluconazole for presumed laryngeal candidiasis. Pathology demonstrated laryngeal cryptococcosis, and sputum cultures grew Cryptococcus neoformans with an elevated fluconazole MIC. Immunological evaluation led to the diagnosis of common variable immunodeficiency. After complications with alternative antifungals, the patient responded favorably to isavuconazole and intravenous immunoglobulin replacement.
SN  - 2211-7539
ER  -